The aim of our group is to understand at the physical chemical level how proteins bind nucleic acids, and to exploit this knowledge to rationally design new proteins and small molecule drugs that control human regulatory networks, or repress viral replication. We use NMR, crystallographic, computational and biochemical techniques to achieve these goals.
